Immunovant, Inc.IMVTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
5Y CAGR+140.9%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+140.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
81.1x
Strong expansion
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $26.62M | +5.6% |
| 2025 | $25.20M | +120.3% |
| 2024 | $11.44M | +527.7% |
| 2023 | $-2.67M | -242.5% |
| 2022 | $-781000.00 | -338.1% |
| 2021 | $328000.00 | +105.0% |
| 2020 | $-6.61M | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $116.00 | - |